This site is intended for healthcare professionals

Bellerophon Therapeutics announces publication of cohort 1 of iNO-PF phase II/III study in the CHEST Journal and participation in webinar to discuss clinical results

Read time: 2 mins
Last updated:1st Jul 2020
Published:22nd Jul 2020
Condition: Pulmonary Arterial Hypertension/ PH + ILD
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest